๐งฌ Studies on Cancer Prevention & Anticancer Mechanisms
Sulforaphane Synergizes With PD-1 Blockade Through Activating CD8(+) T Cells in Non-Small Cell Lung Cancer: Preclinical and Clinical Investigations
Anti-PD-1/PD-L1 therapy has achieved promising success across several tumor types; however, its efficacy is still far from satisfactory in non-small cell lung cancer (NSCLC). Combining therapies have
2026.04.06
1 min read